Concepedia

Enikő Kulcsár

EK

4

Publications

3.6K

Citations

4

H-Index

2009

Active since

Affiliations

Semmelweis University(Current)

Universidad De Santander

Oregon Health & Science University

Universidad de La Frontera

Instituto Dante Pazzanese de Cardiologia

Enikő Kulcsár is an author at Semmelweis University specializing in metabolic syndrome, diabetes, and medicine.

Top concepts

Publications per year

2009–2019

4

Publications

4

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial

Botond Literáti-Nagy, Enikő Kulcsár, Zs. Literáti-Nagy et al. · Hormone and Metabolic Research · 2009 · 112 citations

Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders

Botond Literáti-Nagy, Eva Péterfai, Enikő Kulcsár et al. · Brain Research Bulletin · 2010 · 33 citations

, , +12

Rows per page

1–4 of 4